Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
The Lancet. Infectious Diseases|February 20, 2018
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trialMical Paul, George L Daikos, Emanuele Durante-Mangoni, et al.
JAMA Network Open|July 25, 2025
Adherence to Quality-of-Care Indicators and Mortality Outcomes in Patients With MRSA Bacteremia: A Post Hoc Analysis of the CAMERA2 Randomized Clinical TrialI Russel Lee, Yanan Zhu, Neela J Rai, et al.
BMC Infectious Diseases|April 1, 2021
Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validityVered Daitch, Mical Paul, George L Daikos, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 14, 2025
A time-series analysis approach to quantify change in antibiotic resistance and antibiotic consumption during COVID-19 Epidemics: a multicenter cross-national ecological study on behalf of QUARANTINE (QUantifying change in Antibiotic Resistance, ANTibiotic use, and INfection control during COVID-19 Epidemics) study projectMarianna Meschiari, José María López Lozano, Filippo Medioli, et al.
Open Forum Infectious Diseases|July 27, 2023
Longer-term Mortality and Kidney Outcomes of Participants in the Combination Antibiotics for Methicillin-Resistant Staphylococcus aureus (CAMERA2) Trial: A Post Hoc AnalysisAmy Legg, Matthew A Roberts, Jane Davies, et al.
Pageof 3